Literature DB >> 17885190

Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging.

Jeffrey R Petrella1, Lihong Wang, Sriyesh Krishnan, Melissa J Slavin, Steven E Prince, Thanh-Thu T Tran, P Murali Doraiswamy.   

Abstract

PURPOSE: To prospectively identify brain regions in which task-related changes in activation during a memory encoding task, measured with functional magnetic resonance (MR) imaging, correlate with degree of memory impairment across Alzheimer disease (AD), mild cognitive impairment (MCI), and elderly control subjects.
MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant study, and each patient gave written informed consent. Seventy-five subjects (mean age, 72.9 years+/-7.2 [standard deviation]; 37 men, 38 women)-13 patients with mild AD, 34 individuals with amnestic MCI, and 28 healthy elderly control subjects-were imaged at 4.0 T during novel encoding (NE) and familiar encoding (FE) of face-name pairs presented within a block design for later retrieval. Blood oxygen level-dependent (BOLD) changes were assessed across the entire brain for each group. Between-subject analysis identified brain regions demonstrating a monotonic increase or decrease in activation magnitude, from control subjects to patients with MCI to patients with mild AD. BOLD response was also correlated with score on the delayed portion of the California Verbal Learning Test (CVLT).
RESULTS: In controls, the task elicited positive activation (NE>FE) in the dorsolateral prefrontal, lateral parietal, and medial temporal regions, and negative activation (FE>NE) in the midline frontal and parietal regions. Along the spectrum from control subjects to patients with AD, there was decreasing activation in the medial temporal lobe (MTL), including the hippocampus and parahippocampal and fusiform gyri, and increasing activation in the posteromedial cortices (PMCs), primarily in the precuneus and posterior cingulate gyrus. Activation magnitude in the PMCs significantly (P<.001, r=-0.502) correlated with CVLT score.
CONCLUSION: Compared with activation in the MTL, deactivation in the PMCs could be a more sensitive marker of early AD at functional MR imaging. Copyright (c) RSNA, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885190     DOI: 10.1148/radiol.2451061847

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  53 in total

Review 1.  Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.

Authors:  Amy J Jak; Katherine J Bangen; Christina E Wierenga; Lisa Delano-Wood; Jody Corey-Bloom; Mark W Bondi
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 2.  Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.

Authors:  Bruce A Yankner; Tao Lu
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

3.  Modulation of a human memory circuit by subsyndromal depression in late life: a functional magnetic resonance imaging study.

Authors:  Shoshana L Woo; Steven E Prince; Jeffrey R Petrella; Caroline Hellegers; P Murali Doraiswamy
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

4.  Atrophy and lower regional perfusion of temporo-parietal brain areas are correlated with impairment in memory performances and increase of EEG upper alpha power in prodromal Alzheimer's disease.

Authors:  Vito Davide Moretti
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

5.  fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults.

Authors:  Mehul A Trivedi; Christopher M Murphy; Celine Goetz; Raj C Shah; John D E Gabrieli; Susan Whitfield-Gabrieli; David A Turner; Glenn T Stebbins
Journal:  Dement Geriatr Cogn Disord       Date:  2008-07-28       Impact factor: 2.959

6.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Authors:  Kejal Kantarci; David S Knopman; Dennis W Dickson; Joseph E Parisi; Jennifer L Whitwell; Stephen D Weigand; Keith A Josephs; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

7.  A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.

Authors:  E Sherwood Brown; Hanzhang Lu; Daren Denniston; Jinsoo Uh; Binu P Thomas; Thomas J Carmody; Richard J Auchus; Ramon Diaz-Arrastia; Carol Tamminga
Journal:  J Affect Disord       Date:  2013-02-28       Impact factor: 4.839

8.  Semantic memory activation in amnestic mild cognitive impairment.

Authors:  J L Woodard; M Seidenberg; K A Nielson; P Antuono; L Guidotti; S Durgerian; Q Zhang; M Lancaster; N Hantke; A Butts; S M Rao
Journal:  Brain       Date:  2009-06-10       Impact factor: 13.501

9.  The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Authors:  Guofan Xu; Donald G McLaren; Michele L Ries; Michele E Fitzgerald; Barbara B Bendlin; Howard A Rowley; Mark A Sager; Craig Atwood; Sanjay Asthana; Sterling C Johnson
Journal:  Brain       Date:  2008-10-01       Impact factor: 13.501

10.  Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease.

Authors:  Kathrin Koch; Nicholas E Myers; Jens Göttler; Lorenzo Pasquini; Timo Grimmer; Stefan Förster; Andrei Manoliu; Julia Neitzel; Alexander Kurz; Hans Förstl; Valentin Riedl; Afra M Wohlschläger; Alexander Drzezga; Christian Sorg
Journal:  Cereb Cortex       Date:  2014-07-04       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.